Kaleido Biosciences Inc (KLDO)
0.00
USD |
OTCM |
Nov 13, 16:00
Kaleido Biosciences Total Liabilities (Quarterly): 39.53M for Dec. 31, 2021
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 39.53M |
| September 30, 2021 | 38.60M |
| June 30, 2021 | 34.02M |
| March 31, 2021 | 33.25M |
| December 31, 2020 | 38.85M |
| September 30, 2020 | 37.24M |
| June 30, 2020 | 35.66M |
| March 31, 2020 | 33.20M |
| Date | Value |
|---|---|
| December 31, 2019 | 33.42M |
| September 30, 2019 | 25.17M |
| June 30, 2019 | 25.37M |
| March 31, 2019 | 24.13M |
| December 31, 2018 | 181.57M |
| September 30, 2018 | 178.22M |
| December 31, 2017 | 74.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
33.20M
Minimum
Mar 2020
39.53M
Maximum
Dec 2021
35.98M
Average
35.66M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.14M |
| Shareholders Equity (Quarterly) | 10.61M |